Literature DB >> 21883141

Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies.

Hiroto Inaba, Deepa Bhojwani, Jennifer L Pauley, Deqing Pei, Cheng Cheng, Monika L Metzger, Scott C Howard, Jeffrey E Rubnitz, John T Sandlund, Raul C Ribeiro, Wing Leung, Dario Campana, Ching-Hon Pui, Sima Jeha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21883141      PMCID： PMC3235268          DOI： 10.1111/j.1365-2141.2011.08847.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

1.  Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.

Authors:  E Coustan-Smith; J Sancho; M L Hancock; J M Boyett; F G Behm; S C Raimondi; J T Sandlund; G K Rivera; J E Rubnitz; R C Ribeiro; C H Pui; D Campana
Journal:  Blood       Date:  2000-10-15       Impact factor: 22.113

2.  Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia.

Authors:  David O'Connor; Keith Sibson; Mark Caswell; Philip Connor; Michelle Cummins; Chris Mitchell; Jayashree Motwani; Mary Taj; Ajay Vora; Robert Wynn; Pamela R Kearns
Journal:  Br J Haematol       Date:  2011-06-21       Impact factor: 6.998

3.  DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine.

Authors:  T Yamauchi; B J Nowak; M J Keating; W Plunkett
Journal:  Clin Cancer Res       Date:  2001-11       Impact factor: 12.531

4.  Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias.

Authors:  Stefan Faderl; Varsha Gandhi; Susan O'Brien; Peter Bonate; Jorge Cortes; Elihu Estey; Miloslav Beran; William Wierda; Guillermo Garcia-Manero; Alessandra Ferrajoli; Zeev Estrov; Francis J Giles; Min Du; Monica Kwari; Michael Keating; William Plunkett; Hagop Kantarjian
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

5.  Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia.

Authors:  Beth Kurt; Patricia Flynn; Jerry L Shenep; Stanley Pounds; Shelly Lensing; Raul C Ribeiro; Ching-Hon Pui; Bassem I Razzouk; Jeffrey E Rubnitz
Journal:  Cancer       Date:  2008-07-15       Impact factor: 6.860

6.  Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.

Authors:  Peter Bader; Hermann Kreyenberg; Günter H R Henze; Cornelia Eckert; Miriam Reising; Andre Willasch; Andrea Barth; Arndt Borkhardt; Christina Peters; Rupert Handgretinger; Karl-Walter Sykora; Wolfgang Holter; Hartmut Kabisch; Thomas Klingebiel; Arend von Stackelberg
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

7.  Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia.

Authors:  Franco Locatelli; Anna M Testi; Maria Ester Bernardo; Carmelo Rizzari; Alice Bertaina; Pietro Merli; Andrea Pession; Eugenia Giraldi; Rosanna Parasole; Walter Barberi; Marco Zecca
Journal:  Br J Haematol       Date:  2009-08-29       Impact factor: 6.998

8.  A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia.

Authors:  N Hijiya; P Gaynon; E Barry; L Silverman; B Thomson; R Chu; T Cooper; R Kadota; M Rytting; P Steinherz; V Shen; S Jeha; R Abichandani; W L Carroll
Journal:  Leukemia       Date:  2009-09-10       Impact factor: 11.528
  8 in total
  9 in total

Review 1.  Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.

Authors:  Kelly Faulk; Lia Gore; Todd Cooper
Journal:  Paediatr Drugs       Date:  2014-06       Impact factor: 3.022

2.  Natural killer cell therapy in children with relapsed leukemia.

Authors:  Jeffrey E Rubnitz; Hiroto Inaba; Guolian Kang; Kwan Gan; Christine Hartford; Brandon M Triplett; Mari Dallas; David Shook; Tanja Gruber; Ching-Hon Pui; Wing Leung
Journal:  Pediatr Blood Cancer       Date:  2015-04-30       Impact factor: 3.167

Review 3.  Relapsed and refractory pediatric acute myeloid leukemia: current and emerging treatments.

Authors:  Jennifer Davila; Emily Slotkin; Thomas Renaud
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.022

Review 4.  Childhood acute myeloid leukaemia.

Authors:  Jeffrey E Rubnitz; Hiroto Inaba
Journal:  Br J Haematol       Date:  2012-09-12       Impact factor: 6.998

5.  Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia.

Authors:  K Morrow; C P Hernandez; P Raber; L Del Valle; A M Wilk; S Majumdar; D Wyczechowska; K Reiss; P C Rodriguez
Journal:  Leukemia       Date:  2012-08-28       Impact factor: 11.528

6.  Successful combination chemotherapy involving clofarabine, cyclophosphamide, and etoposide for pediatric relapsed acute myeloid leukemia: A case report.

Authors:  Sachio Fujita; Ryosuke Matsuno; Naoko Kawabata; Yumiko Sugishita; Ryota Kaneko; Masaya Koganesawa; Kosuke Akiyama; Daisuke Toyama; Shohei Yamamoto
Journal:  SAGE Open Med Case Rep       Date:  2021-05-13

7.  Phase 1 study of bendamustine in combination with clofarabine, etoposide, and dexamethasone in pediatric patients with relapsed or refractory hematologic malignancies.

Authors:  Sima Jeha; Kristine R Crews; Deqing Pei; Melissa Peyton; John C Panetta; Raul C Ribeiro; Xujie Zhao; Patrick Campbell; Monika L Metzger; Jun J Yang; Cheng Cheng; Ching-Hon Pui; Deepa Bhojwani
Journal:  Cancer       Date:  2021-02-17       Impact factor: 6.921

8.  French "real life" experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia.

Authors:  Pascale Trioche; Brigitte Nelken; Gérard Michel; Isabelle Pellier; Arnaud Petit; Yves Bertrand; Pierre Rohrlich; Claudine Schmitt; Nicolas Sirvent; Patrick Boutard; Geneviève Margueritte; Brigitte Pautard; Stéphane Ducassou; Dominique Plantaz; Alain Robert; Caroline Thomas; Kristell Desseaux; Sylvie Chevret; André Baruchel
Journal:  Exp Hematol Oncol       Date:  2012-12-10

Review 9.  Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy.

Authors:  Michael A Huang; Deepa K Krishnadas; Kenneth G Lucas
Journal:  J Immunol Res       Date:  2015-10-26       Impact factor: 4.818
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.